Navigate Fool.com
Will FURX beat
the market?
Community Rating: 2 Stars: Unattractive

75.24 -1.88 (-2.44%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $76.98
Previous Close $77.12
Daily Range $74.38 - $78.10
52-Week Range $32.01 - $121.97
Market Cap $798.3M
P/E Ratio -26.41
Dividend (Yield) $0.00 (0.0%)
Volume 199,354
Average Daily Volume 233,629
Current FY EPS -$2.01

How do you think FURX
will perform against the market?

Top FURX Bull/Bear Pitches


TMFDeej (< 20)
Submitted August 17, 2010

Interesting spin-off of PPDI with nearly as much cash on its balance sheet as its market cap.<br /><br />The theory here is that such a small spin-off of such a large company was likely unwanted by ma … More

0 Replies Reply Report this Post

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches here!

News & Commentary Rss Feed

3 Stocks Soaring Higher on These Drug Successes

Three stocks hitting the ceiling today, and the drugs that put them there.

Which Sector Produced 8 Of The 10 Top Percentage Gainers In 2014?

Can You Still Ride Last Month's 3 Best Stocks to Greater Gains?

A big drug breakthrough pushes Furiex Pharmaceuticals into the lead, but Rubicon Minerals and Rentrak are flying high, too.

Does Furiex Pharmaceuticals Inc Still Have Upside Potential?

Furiex shares have soared after reporting late-stage clinical trial results for its irritable bowel syndrome drug. Can it continue to head higher?

This Week in Biotech: Sunny, With No Chance of Rain

Clinical data sends one stock up 137% on the week while a global pharmaceutical company announces three major collaborations ... in one day!

3 Humongous Health-Care Stocks This Week

Find out which health-care stocks celebrated victories as super as the Seattle Seahawks with this week's humongous performers.

Why Furiex Pharmaceuticals Inc. Is an Instant Double

Furiex pulls the classic biotech instant double. How should investors play this fast-moving stock?

Why Furiex Pharmaceuticals, Lionbridge Technologies, and ATMI Are Today's 3 Best Stocks

The S&P 500 stages a modest rebound, Furiex Pharmaceuticals more than doubles, and Lionbridge Technology and ATMI respectively surge by 29% and 25%.

Why Furiex Pharmaceuticals, Inc. Shares Furiously Doubled

Furiex Pharmaceuticals shares rocket 165% following positive late-stage results for its lead drug. Is there still room for this stock to head higher?

Sector Update: Healthcare

See More FURX News...




Diversified Services

Furiex Pharmaceuticals, Inc. (FURX) Description

Furiex Pharmaceuticals Inc. is a drug development collaboration company that uses clinical development strategies to increase the value of partnered pharmaceutical assets and accelerate their development timelines. Website: http://www.furiex.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks